Age‐related factor IX correction in symptomatic female carriers with haemophilia B Leyden

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2516|21|6|e498-e500

ISSN： 1351-8216

Source： HAEMOPHILIA, Vol.21, Iss.6, 2015-11, pp. : e498-e500

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of age on factor IX levels in symptomatic carriers of Haemophila B Leyden

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 3, 2015-05 ,pp. : 448-449

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic determinants of immunogenicity to factor IX during the treatment of haemophilia B

By  

HAEMOPHILIA, Vol. 21, Iss. 2, 2015-03 ,pp. : 210-218

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recombinant factor IX (BAX326) in previously treated paediatric patients with haemophilia B: a prospective clinical trial

By  

HAEMOPHILIA, Vol. 21, Iss. 2, 2015-03 ,pp. : 196-203

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients

By  

HAEMOPHILIA, Vol. 24, Iss. 1, 2018-01 ,pp. : 104-112

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular Analysis of Factor IX Gene in an Iranian Female with Severe Hemophilia B

By  

Acta Haematologica, Vol. 119, Iss. 3, 2008-04 ,pp. : 151-153

Karger

Access to resources Recommend Favorite